Abstract:Background: Conventional approaches to drug discovery are often characterized by lengthy and costly processes. To expedite the discovery of new drugs, the integration of artificial intelligence (AI) in predicting drug-target binding affinity (DTA) has emerged as a crucial approach. Despite the proliferation of deep learning methods for DTA prediction, many of these methods primarily concentrate on the amino acid sequence of proteins. Yet, the interactions between drug compounds and targets occur within distinct segments within the protein structures, whereas the primary sequence primarily captures global protein features. Consequently, it falls short of fully elucidating the intricate relationship between drugs and their respective targets. Objective: This study aims to employ advanced deep-learning techniques to forecast DTA while incorporating information about the secondary structure of proteins. Methods: In our research, both the primary sequence of protein and the secondary structure of protein were leveraged for protein representation. While the primary sequence played the role of the overarching feature, the secondary structure was employed as the localized feature. Convolutional neural networks and graph neural networks were utilized to independently model the intricate features of target proteins and drug compounds. This approach enhanced our ability to capture drugtarget interactions more effectively Results: We have introduced a novel method for predicting DTA. In comparison to DeepDTA, our approach demonstrates significant enhancements, achieving a 3.9% increase in the Concordance Index (CI) and a remarkable 34% reduction in Mean Squared Error (MSE) when evaluated on the KIBA dataset. Conclusion: In conclusion, our results unequivocally demonstrate that augmenting DTA prediction with the inclusion of the protein's secondary structure as a localized feature yields significantly improved accuracy compared to relying solely on the primary structure.

Prediction of protein–ligand binding affinity via deep learning models

DLSSAffinity: Protein-Ligand Binding Affinity Prediction Via a Deep Learning Model

Structure-based, deep-learning models for protein-ligand binding affinity prediction

Prediction of Drug-Target Binding Affinity Based on Deep Learning Models

Advances in Protein-Ligand Binding Affinity Prediction via Deep Learning: A Comprehensive Study of Datasets, Data Preprocessing Techniques, and Model Architectures

DEELIG: A Deep Learning Approach to Predict Protein-Ligand Binding Affinity

Deep learning in modelling the protein–ligand interaction: new pathways in drug development

DeepDTAF: a deep learning method to predict protein–ligand binding affinity

Protein-ligand binding affinity prediction: Is 3D binding pose needed?

A new paradigm for applying deep learning to protein–ligand interaction prediction

Binding Affinity Prediction: From Conventional to Machine Learning-Based Approaches

Scoring Functions for Protein-Ligand Binding Affinity Prediction Using Structure-based Deep Learning: A Review

On Machine Learning Approaches for Protein-Ligand Binding Affinity Prediction

Machine Learning for Sequence and Structure-Based Protein–Ligand Interaction Prediction

Prediction of Protein-Ligand Binding Affinity by a Hybrid Quantum-Classical Deep Learning Algorithm

Improved prediction of ligand-protein binding affinities by meta-modeling

Enhancing Drug-Target Binding Affinity Prediction through Deep Learning and Protein Secondary Structure Integration

From machine learning to deep learning: Advances in scoring functions for protein–ligand docking

Predicting the Protein-Ligand Affinity from Molecular Dynamics Trajectories

Development and evaluation of a deep learning model for protein-ligand binding affinity prediction

Artificial intelligence in the prediction of protein–ligand interactions: recent advances and future directions